Dimensional Fund Advisors
KNSA icon

Dimensional Fund Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Dimensional Fund Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.9M Buy
874,786
+62,864
+8% +$3.26M 0.01% 1546
2026
Q1 		$39.1M Buy
811,922
+128,417
+19% +$5.69M 0.01% 1635
2025
Q4 		$28.2M Buy
683,505
+51,382
+8% +$2.06M 0.01% 1807
2025
Q3 		$24.5M Sell
632,123
-16,213
-3% -$527K 0.01% 1887
2025
Q2 		$17.9M Sell
648,336
-123,967
-16% -$3.16M ﹤0.01% 2022
2025
Q1 		$17.2M Buy
772,303
+696
+0.1% +$14.3K ﹤0.01% 2011
2024
Q4 		$15.3M Buy
771,607
+29,300
+4% +$669K ﹤0.01% 2125
2024
Q3 		$18.6M Buy
742,307
+78,267
+12% +$1.91M ﹤0.01% 2036
2024
Q2 		$12.4M Buy
664,040
+157,741
+31% +$2.96M ﹤0.01% 2166
2024
Q1 		$9.99M Buy
506,299
+156,546
+45% +$3.06M ﹤0.01% 2310
2023
Q4 		$6.13M Sell
349,753
-23,968
-6% -$394K ﹤0.01% 2502
2023
Q3 		$6.49M Sell
373,721
-1,388
-0.4% -$23.4K ﹤0.01% 2439
2023
Q2 		$5.28M Sell
375,109
-2,149
-0.6% -$28.8K ﹤0.01% 2505
2023
Q1 		$4.06M Sell
377,258
-15,533
-4% -$205K ﹤0.01% 2545
2022
Q4 		$5.88K Sell
392,791
-675
-0.2% -$9.83K ﹤0.01% 2395
2022
Q3 		$5.05M Sell
393,466
-13,681
-3% -$156K ﹤0.01% 2422
2022
Q2 		$3.95M Buy
407,147
+46,207
+13% +$431K ﹤0.01% 2517
2022
Q1 		$3.59M Buy
360,940
+201,622
+127% +$2.14M ﹤0.01% 2635
2021
Q4 		$1.88M Buy
159,318
+25,031
+19% +$308K ﹤0.01% 2862
2021
Q3 		$1.53M Sell
134,287
-193,927
-59% -$2.53M ﹤0.01% 2925
2021
Q2 		$4.57M Buy
328,214
+90,167
+38% +$1.37M ﹤0.01% 2638
2021
Q1 		$4.41M Buy
238,047
+163,191
+218% +$3.34M ﹤0.01% 2625
2020
Q4 		$1.32M Buy
74,856
+4,609
+7% +$81K ﹤0.01% 2917
2020
Q3 		$1.08M Buy
70,247
+5,167
+8% +$97K ﹤0.01% 2911
2020
Q2 		$1.66M Sell
65,080
-791
-1% -$16.5K ﹤0.01% 2816
2020
Q1 		$1.02M Buy
65,871
+39,181
+147% +$613K ﹤0.01% 2887
2019
Q4 		$295K Buy
+26,690
New +$232K ﹤0.01% 3215

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Dimensional Fund Advisors's KNSA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Kiniksa Pharmaceuticals (KNSA) stake by 7.7% in Q2 2026, buying an estimated $3.26M and bringing the position to 874,786 shares worth $55.9M. The position accounts for 0.01% of the portfolio, ranked #1546.

Dimensional Fund Advisors first reported a position in KNSA in Q4 2019 and has held it in 27 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Dimensional Fund Advisors held 874,786 shares of Kiniksa Pharmaceuticals worth $55.9M as of Q2 2026.
  • Dimensional Fund Advisors bought 62,864 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $3.26M.
  • Kiniksa Pharmaceuticals made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1546 holding.
  • Dimensional Fund Advisors first reported a position in Kiniksa Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.